GOP raises concerns over Trump drug pricing proposal

    Trump drug pricing proposal

    A proposal from President Donald Trump to lower the drug prices in Medicare is seeing some obstacles from the Republican opposition.

    In an attempt to lower the drug prices in the US, Trump had proposed to base payments for certain drugs off of lower prices in other countries, in October.

    During a speech at the Department of Health and Human Services (HHS), Trump had said, “Same company, same box, same pill, made in the exact same location. And you go to some countries and it would be 20 percent of what we pay.” He further added, “We’re fixing it.”

    On Tuesday, a union of conservative groups, including Americans for Tax Reform and FreedomWorks wrote a letter to demand the withdrawal of the proposal.

    On Thursday, HHS Secretary Alex Azar was questioned by the GOP lawmakers about the Trump drug pricing plan. Senate Finance Committee Chairman Orrin Hatch (R-Utah) also raised concerns about the proposal with other GOP senators.

    From a long time, Trump administration has been criticizing drug companies for charging whatever they want. The officials insist on changing the system.

    What worries critics is the proposal might import price controls from other countries. Rep. Larry Bucshon (R-Ind.), a GOP lawmaker who publicly criticized the plan, said: “I understand that we do want to get drug prices down but I think that any proposal that would lead to government price-fixing in that space is a pathway we don’t want to follow.”

    As of now, Trump administration is not ready to give up. Instead, it is willing to fight the pharmaceutical industry and impose the Trump drug pricing plan.

    The administration will face trouble if Sen. Chuck Grassley (R-Iowa), who will be the Chairman of the Finance Committee from January, would oppose the proposal.

    A spokesperson of Grassley said, “Portions of the Administration’s proposal raise concerns about the possibility of importing price controls from other countries.” He further added that while foreign countries might not be paying their share for drugs, “the creation of price controls is not the solution.”

    On the other hand, there are more Democrats supporting Trump’s proposal than Republicans. A similar proposal was withdrawn under former President Obama due to industry and congressional opposition.

    However, Sen. Thom Tillis (R-N.C.) warned against the proposal, saying “The recovery period for all the money you put into a drug to begin with gets stretched out and therefore all these things you’d like to work on and research have to wait.”

    The administration is hearing out all the concerns raised. The HHS spokesperson said that Azar has been “meeting and talking with many members of Congress across the aisle to discuss” the Trump drug pricing plan.


    • Elena Cooper has worked in the immigration sector as a freelance writer for more than 7 years. She has worked with non-profit, corporate to government organizations in the category of immigration issues and updates. Elena has used her opportunity of working with Ask The Truth to the utmost level at raising awareness by talking about issues in the immigration sector.

    • Show Comments (0)

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    You May Also Like

    Kentucky Medicaid

    Work requirements re-approved for Kentucky’s Medicaid by Trump Administration

    Kentucky’s appeal to compel many of its low-income residents on Medicaid to get jobs ...


    Obamacare Repeal Prompts Threat for Trump in Re-Elections

    Healthcare in the United States has become a major constituent of its political landscape, ...

    Heart diseases

    Certain pain medications said to increase heart risks

    According to a new study use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with ...

    pesticides in US market

    Harmful Pesticide to be Removed from U.S. Market by Court Orders

    The Trump administration endangered public health by keeping the extensively used pesticide chlorpyrifos on ...

    Alzheimer’s disease

    Put money into Alzheimer’s research, Dem Sen. Ed Markey insists

    Alzheimer’s disease needs a lot more research before a cure is found. And while ...